Warning: The NCBI web site requires JavaScript to function. more...
MethMarker: user-friendly design and optimization of gene-specific DNA methylation assays.
Schüffler P, Mikeska T, Waha A, Lengauer T, Bock C.
Genome Biol. 2009;10(10):R105. Epub 2009 Oct 5.
Related citations
Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H.
Int J Oncol. 2008 Sep;33(3):469-75.
Favoritism in DNA methylation.
Hitchins MP, Ward RL.
Cancer Prev Res (Phila). 2009 Oct;2(10):847-9. Epub 2009 Sep 29. Review.
[DNA methylation. From basic research to routine diagnostics].
Lehmann U.
Pathologe. 2010 Oct;31 Suppl 2:274-9. German.
Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Löf-Ohlin ZM, Nilsson TK.
Oncol Rep. 2009 Mar;21(3):721-9.
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.
Life Sci. 2010 Jul 17;87(3-4):83-91. Epub 2010 May 12.
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Weller M, Stupp R, Reifenberger G, Brandes AA, van den Bent MJ, Wick W, Hegi ME.
Nat Rev Neurol. 2010 Jan;6(1):39-51. Epub 2009 Dec 8. Review.
MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.
Hawkins NJ, Lee JH, Wong JJ, Kwok CT, Ward RL, Hitchins MP.
Mod Pathol. 2009 Dec;22(12):1588-99. Epub 2009 Sep 4.
Detecting methylation patterns of p16, MGMT, DAPK and E-cadherin genes in multiple myeloma patients.
Yuregir OO, Yurtcu E, Kizilkilic E, Kocer NE, Ozdogu H, Sahin FI.
Int J Lab Hematol. 2010 Apr;32(2):142-9. Epub 2009 Mar 2.
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas.
Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, Reifenberger G, Tonn JC, Kretzschmar HA.
Int J Cancer. 2007 Dec 1;121(11):2458-64.
Quantitation of DNA methylation by melt curve analysis.
Smith E, Jones ME, Drew PA.
BMC Cancer. 2009 Apr 24;9:123.
Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.
Taioli E, Ragin C, Wang XH, Chen J, Langevin SM, Brown AR, Gollin SM, Garte S, Sobol RW.
BMC Cancer. 2009 Oct 6;9:354.
MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas.
Jeuken JW, Cornelissen SJ, Vriezen M, Dekkers MM, Errami A, Sijben A, Boots-Sprenger SH, Wesseling P.
Lab Invest. 2007 Oct;87(10):1055-65. Epub 2007 Aug 13.
Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism.
Candiloro IL, Dobrovic A.
Cancer Prev Res (Phila). 2009 Oct;2(10):862-7. Epub 2009 Sep 29.
MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
Uccella S, Cerutti R, Placidi C, Marchet S, Carnevali I, Bernasconi B, Proserpio I, Pinotti G, Tibiletti MG, Furlan D, Capella C.
J Clin Pathol. 2009 Aug;62(8):715-23.
[Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):831-6. Chinese.
[Strategy for studying gene methylation: the example of MGMT].
Fina F, Nanni-Metellus I, Courdy C, Figarella-Branger D, Martin PM, Ouafik L.
Ann Pathol. 2009 Nov;29 Spec No 1:S37-9. Epub 2009 Oct 6. Review. French. No abstract available.
Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J, Kim DH.
Clin Cancer Res. 2009 Oct 1;15(19):6185-91. Epub 2009 Sep 22.
Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
Hoffmann AC, Kaifi JT, Vallböhmer D, Yekebas E, Grimminger P, Leers JM, Izbicki JR, Hölscher AH, Schneider PM, Metzger R, Brabender J.
J Surg Oncol. 2009 Oct 1;100(5):414-7.
Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.
Hiraki M, Kitajima Y, Sato S, Mitsuno M, Koga Y, Nakamura J, Hashiguchi K, Noshiro H, Miyazaki K.
Ann Surg Oncol. 2010 Apr;17(4):1177-86. Epub 2009 Dec 3.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on